IKONISYS overview

Regulatory News: Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant of a new U.S. patent by the United States Patent and Trademark Office (USPTO) entitled “Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments” . Commercially known as “ACTA Technology” (Automated Cancer Treatment Assessment) , this milestone...

Regulatory News: Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has secured a public tender for the Azienda Ospedaliera Universitaria "Gaetano Martino" in Messina, Italy. The contract, valued at €668 thousand over three years, includes an option to extend it for two additional years, bringing the total potential value to €1.025 million . The tender covers the supply...

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “ Issuer ”), today announces a capital increase of 300k€ through the offsetting of debt owed to Cambria KOP BV, a Dutch investment company, and the emission of 196,080 shares of the Company. This operation strengthens the Company's net financial position and broadens its...

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “ Issuer ”), today announces that it has completed the acquisition of Hospitex International Srl, with the issuance of 2 million new Ikonisys shares to ETH Scientific Srl, the former owner of Hospitex. As disclosed in November 2023, Ikonisys signed an agreement to buy 100% of...

Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories, is proud to announce the launch of its new vision and strategy under the brand “ ALIKO SCIENTIFIC ” ( www.alikoscientific.com ). This pivotal development introduces a renewed corporate identity and business vision, marking the Group’s transformation into a global...

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories, today announces the achievement of a significant milestone in its commercial journey through its wholly owned subsidiary, Hospitex. Just eight months after its integration into the Group, Hospitex has been awarded another prestigious public tender to supply the innovative Ikoniscope20...

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “ Issuer ”), today announces that it has completed a capital increase of €200k, by way of a private placement. This operation is part of the ongoing series of recent capital increases aimed at strengthening the Company's financial stability and diversifying its shareholder...

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO) , a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories, today announces the signing of a distribution agreement with Green Med, a major distributor of medical devices in Panama and Central America. This collaboration is part of a strategic initiative, which aims at bringing innovative cytological and oncological diagnostics to the region, based...